This is the authors' abstract. We don't add key points for this paper.
This video article presents the phase III ADAURA study investigating osimertinib in the treatment of early-stage EGFR-mutated NSCLC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Thomas John (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: